跳至主要内容
临床试验/NCT01646723
NCT01646723已完成不适用

Volunteers Adding Life in Dementia (VALID)

Queen's University2 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
2
主要终点
Change in Cohen-Mansfield Agitation Inventory (CMAI) score

研究概览

简要总结

The objectives of our project are to: 1.) Develop a training program and manual for volunteers to implement evidence-based, non-pharmacological interventions for neuropsychiatric symptoms (NPS) of dementia in long-term care (LTC) settings; 2.) Recruit and train volunteers using the VALID program and pilot test the volunteer-led program with 20 individuals with Alzheimer's disease and NPS in a LTC facility in Kingston; and, 3.) Evaluate the effects of the VALID program on the symptoms of NPS, patient quality of life, volunteer's experience, and LTC staff stress.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of Alzheimer's disease or related forms of dementia
  • significant symptoms of agitation as measured by a Cohen-Mansfield Agitation Inventory (CMAI) total score of >39
  • in nursing home for at least 30 days
  • presence of a caregiver or substitute decision maker willing to consent to treatment
  • no changes in psychotropic medications in the 2 weeks preceding enrolment in study

排除标准

  • depressive symptoms presenting risk
  • physically aggressive behavior posing safety risk to others
  • uncontrolled pain
  • currently receiving palliative care
  • medically unstable with life expectancy of < 6 months
  • currently awaiting transfer to another LTC facility or hospital.

结局指标

主要结局

Change in Cohen-Mansfield Agitation Inventory (CMAI) score

时间窗: Baseline and 12 weeks

次要结局

  • Clinically significant reduction in agitation(Baseline and 12 weeks)
  • Change in depression symptoms (Cornell Depression in Dementia Rating Scale)(Baseline and 12 weeks)
  • Change in Modified Nursing Care Assessment Scale score(Baseline and 12 weeks)
  • Clinical Global Impression of Change (CGI-C)(Baseline and 12 weeks)
  • Remission of neuropsychiatric symptoms(Baseline and 12 weeks)
  • Change in Neuropsychiatric Inventory (NPI) score(Baseline and 12 weeks)
  • Use and dose of required medication(Baseline and 12 weeks)
  • Dementia Quality of Life (DemQoL) Scale(Baseline and 12 weeks)
  • Short form health survey(Baseline and 12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Dallas Seitz

MD

Queen's University

研究点 (2)

Loading locations...

相似试验